DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD lifted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,266,781 shares of the medical instruments supplier’s stock after buying an additional 343,915 shares during the period. Price T Rowe Associates Inc. MD’s holdings in DENTSPLY SIRONA were worth $207,995,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in XRAY. Raymond James & Associates boosted its position in DENTSPLY SIRONA by 29.8% during the 4th quarter. Raymond James & Associates now owns 1,021,226 shares of the medical instruments supplier’s stock worth $36,345,000 after acquiring an additional 234,322 shares during the period. Raymond James Financial Services Advisors Inc. grew its position in DENTSPLY SIRONA by 123.8% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 13,706 shares of the medical instruments supplier’s stock valued at $488,000 after buying an additional 7,583 shares in the last quarter. State of Alaska Department of Revenue increased its stake in DENTSPLY SIRONA by 11.2% during the 4th quarter. State of Alaska Department of Revenue now owns 69,686 shares of the medical instruments supplier’s stock valued at $2,479,000 after buying an additional 7,000 shares during the period. Mayfair Advisory Group LLC raised its position in shares of DENTSPLY SIRONA by 44.7% during the 4th quarter. Mayfair Advisory Group LLC now owns 10,170 shares of the medical instruments supplier’s stock worth $362,000 after buying an additional 3,144 shares in the last quarter. Finally, DAVENPORT & Co LLC bought a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $1,220,000. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Down 0.1 %

Shares of NASDAQ XRAY traded down $0.02 during mid-day trading on Friday, reaching $26.41. The company had a trading volume of 1,748,732 shares, compared to its average volume of 2,495,531. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43. The company has a market capitalization of $5.48 billion, a price-to-earnings ratio of -60.02, a PEG ratio of 1.18 and a beta of 1.01. The stock has a fifty day moving average of $26.32 and a two-hundred day moving average of $30.34. DENTSPLY SIRONA Inc. has a 12-month low of $23.94 and a 12-month high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, meeting the consensus estimate of $0.42. The firm had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.39 EPS. As a group, equities research analysts expect that DENTSPLY SIRONA Inc. will post 2.02 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Friday, June 28th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, June 28th. This represents a $0.64 dividend on an annualized basis and a yield of 2.42%. DENTSPLY SIRONA’s payout ratio is -145.45%.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier purchased 3,577 shares of DENTSPLY SIRONA stock in a transaction dated Friday, May 31st. The stock was acquired at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the acquisition, the director now directly owns 58,374 shares in the company, valued at $1,631,553.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.52% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on XRAY. The Goldman Sachs Group dropped their target price on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday, May 6th. Stifel Nicolaus cut their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Piper Sandler reaffirmed a “neutral” rating and set a $32.00 target price (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Finally, StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA has an average rating of “Moderate Buy” and a consensus price target of $33.67.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.